About this trial
An Italian randomized controlled trial parallel-group in patients with a malignant tumor of the right or proximal transverse colon requiring right hemicolectomy.
Eligibility criteria
Qualifiers
American Society of Anesthesiologists(ASA) grade I-III.
Right colon cancer (*The right-sided location of the cancer is defined as the location from the caecum up to the proximal third of the transverse colon), preoperative assessment of tumor stage T2-T4a, any N or T any N+ according to the National Comprehensive Cancer Network(NCCN) clinical practice guidelines in oncology: colon cancer version 2.2015); no distant metastasis.
Informed consent
Disqualifiers
Age > 85 years old.
T1, N0
T4b, any N
BMI > 30.
Trial design
Treatments tested in this trial
- Conventional Right hemicolectomy (Non-CME)
- Right hemicolectomy with CME+CVL
Treatment groups
Sponsors and collaborators
University of Turin, Italy
Lead sponsor
Federico II University
Collaborator
Agnelli Hospital, Italy
Collaborator
Ospedale della Misericordia
Collaborator
Candiolo Cancer Institute - IRCCS
Collaborator
Maggiore Bellaria Hospital, Bologna
Collaborator
Università degli Studi di Ferrara
Collaborator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborator
Azienda Ospedaliera Universitaria Policlinico "G. Martino"
Collaborator
Ospedale Policlinico San Martino
Collaborator
University of Rome Tor Vergata
Collaborator
S. Andrea Hospital
Collaborator
European Institute of Oncology
Collaborator